Predicted to enable RNA binding activity. Predicted to be involved in regulation of alternative mRNA splicing, via spliceosome. Predicted to act upstream of or within negative regulation of myoblast differentiation. Predicted to be active in cytoplasm and nucleoplasm. Orthologous to human MBNL3 (muscleblind like splicing regulator 3). [provided by Alliance of Genome Resources, Apr 2022]